Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 79293649 |
Registration Number | 6297700 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
2020-07-20 | Application Filed |
2020-09-17 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
2020-09-17 | Status: Live/Pending |
2020-09-18 | Transaction Date |
2021-03-23 | Trademark Registered |
Owner: | ![]() |
Address | CH-4002 Basel CH |
Legal Entity Type | Aktiengesellschaft (ag) |
Legal Entity State | CH |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 9 |
U.S. Codes: | 021,023,026,036,038 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0091 | Software or software applications for medical or surgical purposes; computer software, namely, chatbots enabling users to query an analytical system on a web page or a mobile tool through natural voice for generating and simulating conversations in the field of health or pharmaceutical products; online available or downloadable software applications for medical and/or surgical applications; mobile applications for medical purposes; data collection devices |
GS0091 | Recorded and downloadable software for medical purposes, namely, software for use in allowing users to query an analytical system in the field of healthcare and pharmaceutical products; recorded and downloadable software applications for medical purposes, namely, intelligent personal assistant software for voice recognition and natural language processing for the purposes of monitoring and improving patient health; recorded and downloadable computer software, namely, chatbot software enabling users to use natural voice to query an analytical system through a Web page or mobile tool for generating and simulating conversations in the field of health and pharmaceutical products; recorded and downloadable software applications for medical applications, namely, software for collecting, processing, transmitting and displaying medical data collected from medical patient monitoring equipment; downloadable mobile applications for receiving, processing, transmitting data collected from patients and from patient monitoring equipment for the purpose of providing information regarding pharmaceutical products and healthcare; data collection devices, namely, electronic monitors for use in receiving, processing, transmitting and displaying medical data collected from patients and from medical patient monitoring equipment |
Description | Date | Event Coding |
---|---|---|
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2020-09-17 | 1 REPR M: |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-09-18 | 2 NWOS I:Incoming Correspondence |
APPLICATION FILING RECEIPT MAILED | 2020-09-22 | 3 MAFR O:Outgoing Correspondence |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-10-02 | 4 COAR I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-10-02 | 5 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-10-02 | 6 ARAA I:Incoming Correspondence |
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2020-10-02 | 7 ECDR I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-10-02 | 8 TCCA I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-10-02 | 9 CHAN I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2020-10-05 | 10 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2020-10-05 | 11 CNRT R:Renewal |
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2020-10-06 | 12 RFCR E:E-Mail |
REFUSAL PROCESSED BY MPU | 2020-10-29 | 13 RFRR P: |
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2020-10-30 | 14 RFCS P: |
REFUSAL PROCESSED BY IB | 2020-11-22 | 15 RFNT P: |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-11-24 | 16 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-11-24 | 17 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-11-24 | 18 TEME I:Incoming Correspondence |
EXAMINERS AMENDMENT -WRITTEN | 2020-11-30 | 19 CNEA R:Renewal |
EXAMINERS AMENDMENT E-MAILED | 2020-11-30 | 20 GNEA O:Outgoing Correspondence |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2020-11-30 | 21 GNEN O:Outgoing Correspondence |
EXAMINER'S AMENDMENT ENTERED | 2020-11-30 | 22 XAEC I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-11-30 | 23 CNSA O:Outgoing Correspondence |
ASSIGNED TO LIE | 2020-11-30 | 24 ALIE A:Allowance for Publication |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-12-16 | 25 NONP E:E-Mail |
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2020-12-23 | 26 OP2R P: |
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2020-12-23 | 27 OPNS P: |
PUBLISHED FOR OPPOSITION | 2021-01-05 | 28 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-01-05 | 29 NPUB E:E-Mail |
NOTIFICATION PROCESSED BY IB | 2021-01-11 | 30 GPNX P: |
REGISTERED-PRINCIPAL REGISTER | 2021-03-23 | 31 R.PR A:Allowance for Publication |
DEATH OF INTERNATIONAL REGISTRATION | 2021-06-06 | 32 DETH P: |
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | 2021-06-06 | 33 DENC E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.